ストックスクリーナーアプリを入手
3.87
4.91%
-0.20
前日終値:
$4.07
開ける：
$3.97
24時間の取引高:
439.45K
Relative Volume:
0.38
時価総額：
$143.79M
収益：
$59.63M
当期純損益:
$-72.21M
株価収益率:
-1.8429
EPS:
-2.1
ネットキャッシュフロー:
$-30.85M
1週間 パフォーマンス:
-4.44%
1か月 パフォーマンス:
+72.77%
6か月 パフォーマンス:
+14.16%
1年 パフォーマンス:
-41.45%
1日の値動き範囲:
$3.855
$4.16
1週間の範囲:
$3.85
$4.57
52週間の値動き範囲:
$1.81
$7.4802
908 Devices Inc Stock (MASS) Company Profile
MASS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
3.87 | 143.79M | 59.63M | -72.21M | -30.85M | -2.10 |
|
ABT
Abbott Laboratories
|
131.69 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.03 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
376.99 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.67 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.78 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
908 Devices Inc Stock (MASS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-13 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-02-07 | 開始されました | Stephens | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-01-12 | 開始されました | Cowen | Outperform |
| 2021-01-12 | 開始されました | SVB Leerink | Outperform |
| 2021-01-12 | 開始されました | Stifel | Buy |
| 2021-01-12 | 開始されました | William Blair | Outperform |
すべてを表示
908 Devices Inc (MASS) 最新ニュース
Charles Schwab Investment Management Inc. Has $444,000 Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices (NASDAQ:MASS) Given Sell (E+) Rating at Weiss Ratings - Defense World
Q1 Earnings Estimate for 908 Devices Issued By William Blair - Defense World
908 Devices (MASS) Stock Jumps on Strength of New Order Announcement - Stocks Telegraph
908 Devices gets $1.7M order from Ministry of Health of Ukraine - MSN
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device - 01net
908 Devices climbs on $1.7 mln order from Ukraine - TradingView
908 Devices secures $1.7 million order from Ukraine - Investing.com India
908 Devices secures $1.7 million order from Ukraine By Investing.com - Investing.com South Africa
908 Devices Receives $1.7M Order From The Ministry Of Health Of Ukraine For Its Handheld Mass Spec Device - Marketscreener.com
Major Win: Ukraine Orders $1.7M of 908 Devices' Advanced Threat Detection Tech - StockTitan
What Is The Outlook For 908 Devices Inc (NASDAQ: MASS) Like For Short-Term? - Stocks Register
908 Devices: Strategic Divestiture and Strong Financial Performance Drive Buy Rating - TipRanks
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
Weiss Ratings Reaffirms Sell (E+) Rating for 908 Devices (NASDAQ:MASS) - Defense World
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - MSN
908 Devices Inc. SEC 10-K Report - TradingView
Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online
908 Devices Makes Key Divestiture (Rating Upgrade) (NASDAQ:MASS) - Seeking Alpha
908 Devices earnings missed by $0.33, revenue fell short of estimates - Investing.com Australia
Stifel maintains Buy on 908 Devices, target steady at $6 By Investing.com - Investing.com Canada
Stifel maintains Buy on 908 Devices, target steady at $6 - Investing.com India
908 Devices Inc. Reports Strategic Transformation and Growth - MSN
Repligen lays down $70m to buy analytics tech from 908 Devices - BioProcess Insider
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices - Genetic Engineering & Biotechnology News
908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors - Simply Wall St
908 Devices Inc (MASS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
908 Devices stock surges on strategic transformation and growth outlook By Investing.com - Investing.com South Africa
908 Devices stock surges on strategic transformation and growth outlook - Investing.com
Repligen Corporation acquired the assets related to bioprocessing analytics portfolio of 908 Devices Inc. for $56 million. - Marketscreener.com
908 Devices jumps as Repligen buys bioprocessing analytics portfolio - MSN
Earnings call transcript: 908 Devices Q4 2024 revenue up 31%, stock surges - Investing.com India
MASS’s 2023 Market Dance: Up 66.78% – Time to Invest? - The InvestChronicle
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth - Benzinga India
Strategic Divestment and Focus on Growth Propel 908 Devices to a Buy Rating - TipRanks
908 Devices reports Q4 EPS (56c), consensus (35c) - TipRanks
908 Devices Inc. reports results for the quarter ended December 31Earnings Summary - TradingView
Repligen Corporation acquired Bioprocessing Analytics Portfolio from 908 Devices Inc. for $70 million. - Marketscreener.com
Repligen’s Strategic Acquisition of 908 Devices’ Bioprocessing Assets Boosts Buy Rating - TipRanks
MASSive Gains for 908 Devices: Is This Stock Turning Around? - RagingBull
908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Investor presentation (03/04/2025 00: 00 - Marketscreener.com
Repligen Acquires 908 Devices’ Bioprocess Analytics Portfolio - Contract Pharma
908 DEVICES Earnings Results: $MASS Reports Quarterly Earnings - Nasdaq
908 Devices stock jumps on Repligen deal (RGEN:NASDAQ) - Seeking Alpha
908 Devices sells desktop assets, sees revenue growth - Investing.com India
908 Devices stock soars on divestiture and revenue growth By Investing.com - Investing.com Canada
Repligen acquires 908 Devices’ desktop bioprocessing tech By Investing.com - Investing.com South Africa
908 Devices stock soars on divestiture and revenue growth - Investing.com
908 Devices Inc (MASS) 財務データ
収益
当期純利益
現金流量
EPS
908 Devices Inc (MASS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Turner Michael S. | Chief Legal & Admin Officer |
Feb 03 '25 |
Sale |
2.33 |
9,672 |
22,499 |
24,603 |
| Knopp Kevin J. | President and CEO |
Feb 03 '25 |
Sale |
2.32 |
16,001 |
37,109 |
692,733 |
| Brown Christopher D. | Chief Product Officer |
Feb 03 '25 |
Sale |
2.34 |
7,767 |
18,191 |
962,122 |
| Brown Christopher D. | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
1.58 |
55,131 |
87,107 |
946,453 |
| Knopp Kevin J. | President and CEO |
Dec 13 '24 |
Option Exercise |
1.63 |
158,044 |
257,771 |
667,025 |
| Brown Christopher D. | Chief Product Officer |
Aug 07 '24 |
Option Exercise |
1.58 |
6,328 |
9,998 |
891,322 |
| Eisenberg Marcia | Director |
Jun 07 '24 |
Option Exercise |
0.00 |
682 |
0 |
6,816 |
| Knopp Kevin J. | President and CEO |
May 13 '24 |
Buy |
6.42 |
10,000 |
64,200 |
508,981 |
| Knopp Kevin J. | President and CEO |
May 10 '24 |
Buy |
5.77 |
10,000 |
57,700 |
498,981 |
| Knopp Kevin J. | President and CEO |
May 09 '24 |
Buy |
5.83 |
10,000 |
58,300 |
488,981 |
0.44%
0.15%
大文字化:
|
ボリューム (24 時間):